{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:13:34Z","timestamp":1785500014125,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.earlhumdev.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T16:59:04Z","timestamp":1328893144000},"page":"609-615","source":"Crossref","is-referenced-by-count":13,"title":["Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure"],"prefix":"10.1016","volume":"88","author":[{"given":"Ken","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Oberlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.323.7307.257","article-title":"Cohort study of depressed mood during pregnancy and after childbirth","volume":"323","author":"Evans","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":"Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes","volume":"166","author":"Wisner","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ajp.2008.08060817","article-title":"Selective serotonin reuptake inhibitor use and risk of gestational hypertension","volume":"166","author":"Toh","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/JCP.0b013e3181bf344c","article-title":"Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction","volume":"29","author":"Toh","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0025","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Eng J Med"},{"issue":"8","key":"10.1016\/j.earlhumdev.2012.01.004_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/00006450-200204000-00008","article-title":"Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response","volume":"51","author":"Oberlander","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0045","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.earlhumdev.2008.06.008","article-title":"Hypothalamic\u2013pituitary\u2013adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure","volume":"84","author":"Oberlander","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0050","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/PCC.0b013e3181c76cdc","article-title":"Neonatal pulmonary hypertension","volume":"11","author":"Steinhorn","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2010","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0085","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","article-title":"Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats","volume":"111","author":"Guignabert","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0090","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1440-1681.2006.04485.x","article-title":"Sertraline protects against monocrotaline-induced pulmonary hypertension in rats","volume":"33","author":"Li","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pupt.2006.01.001","article-title":"Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension","volume":"19","author":"Kawut","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0100","first-page":"H626","article-title":"Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation","volume":"257","author":"Abman","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0105","doi-asserted-by":"crossref","first-page":"L648","DOI":"10.1152\/ajplung.00288.2004","article-title":"Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus","volume":"288","author":"Grover","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0110","first-page":"239","article-title":"Umbilical cord compression produces pulmonary hypertension in newborn lambs: a model to study the pathophysiology of persistent pulmonary hypertension in the newborn","volume":"9","author":"Soifer","year":"1987","journal-title":"J Dev Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0115","doi-asserted-by":"crossref","first-page":"L1475","DOI":"10.1152\/ajplung.00089.2007","article-title":"Role of platelet-activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs","volume":"293","author":"Bixby","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0120","first-page":"H656","article-title":"Filling and arterial pressures as determinants of RV stroke volume in the sheep fetus","volume":"244","author":"Thornburg","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1203\/00006450-198712000-00001","article-title":"Fetal lamb ventricles respond differently to filling and arterial pressures and to in utero ventilation","volume":"22","author":"Reller","year":"1987","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e31821ba11a","article-title":"Third trimester fetal heart rate and doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure","volume":"70","author":"Rurak","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/A:1006934807375","article-title":"Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors","volume":"19","author":"DeVane","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0155","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0002-9378(96)70586-0","article-title":"Fetal branch pulmonary arterial vascular impedance during the second half of pregnancy","volume":"174","author":"Rasanen","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.CIR.94.5.1068","article-title":"Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy","volume":"94","author":"Rasanen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1469-0705.2000.00134.x","article-title":"Human fetal pulmonary artery velocimetry: repeatability and normal values with emphasis on middle and distal pulmonary vessels","volume":"15","author":"Laudy","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0170","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/01.CIR.103.12.1662","article-title":"Cardiac output and central distribution of blood flow in the human fetus","volume":"103","author":"Mielke","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/0002-9149(92)90300-N","article-title":"Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to term","volume":"70","author":"Tan","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000123618","article-title":"Evaluation of normal fetal branch pulmonary artery diameters measured by ultrasonography: a comparison with congenital diaphragmatic hernia","volume":"23","author":"Katayama","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajog.2006.02.009","article-title":"Fetal pulmonary artery diameter measurements as a predictor of morbidity in antenatally diagnosed congenital diaphragmatic hernia: a prospective study","volume":"195","author":"Sokol","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0029-7844(98)00402-5","article-title":"Behavior-state-dependent changes in human fetal pulmonary blood flow velocity waveforms","volume":"93","author":"Macklon","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-3806(01)00255-3","article-title":"Fetal behavioural state changes following maternal fluoxetine infusion in sheep","volume":"131","author":"Morrison","year":"2001","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0200","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1172\/JCI114091","article-title":"Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs","volume":"83","author":"Abman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0205","first-page":"H2303","article-title":"Pulmonary hypertension and vascular remodeling in fetal sheep","volume":"266","author":"Belik","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0210","first-page":"L701","article-title":"Systemic arteriovenous fistula leads to pulmonary artery remodeling and abnormal vasoreactivity in the fetal lamb","volume":"285","author":"Jouannic","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0215","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0220","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":"Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0230","series-title":"Fabaroff and martin's neonatal\u2013perinatal medicine","year":"2011"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2005-872594","article-title":"Cesarean section, gestational age, and transient tachypnea of the newborn: timing is the key","volume":"22","author":"Riskin","year":"2005","journal-title":"Am J Perinatol"},{"issue":"Suppl. 3","key":"10.1016\/j.earlhumdev.2012.01.004_bb0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/14767058.2010.507971","article-title":"Transient tachypnea of the newborn: what is new?","volume":"23","author":"Yurdakok","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00404-010-1473-6","article-title":"Transient tachypnea of the newborn: effects of labor and delivery type in term and preterm pregnancies","volume":"283","author":"Derbent","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/gcen.1998.7216","article-title":"The pulmonary neuroendocrine system and drainage of the fetal lung: effects of serotonin","volume":"113","author":"Chua","year":"1999","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0255","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2350\/07-04-0267.1","article-title":"Pulmonary neuroendocrine cell system in pediatric lung disease-recent advances","volume":"10","author":"Cutz","year":"2007","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0265","first-page":"L185","article-title":"Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung development","volume":"290","author":"Pan","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0270","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","article-title":"Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension","volume":"94","author":"Marcos","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4002007","article-title":"Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications","volume":"13","author":"Oberlander","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2009.06.007","article-title":"Pharmacogenomics of antidepressant drugs","volume":"124","author":"Horstmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.earlhumdev.2012.01.004_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2011.02.008","article-title":"Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G\u00d7G and G\u00d7E differences in health and disease","volume":"11","author":"Murphy","year":"2011","journal-title":"Curr Opin Pharmacol"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378212000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378212000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T10:35:57Z","timestamp":1561286157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378212000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0378378212000096"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2012.01.004","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}